Get Diamond plan for FREE

    logo

    POMDOCTOR Ltd (POM)

    Price:

    0.24 USD

    ( - -0.00 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    POM
    Name
    POMDOCTOR Ltd
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare
    Price
    0.243
    Market Cap
    26.008M
    Enterprise value
    3.917B
    Currency
    USD
    Ceo
    Zhenyang Shi
    Full Time Employees
    156
    Website
    Ipo Date
    2025-10-08
    City
    Guangzhou
    Address
    Yongxu Industrial Park

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    High Tide Inc.

    VALUE SCORE:

    7

    Symbol
    HITI
    Market Cap
    308.887M
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare

    2nd position

    Insmed Incorporated

    VALUE SCORE:

    7

    Symbol
    INSM
    Market Cap
    31.979B
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare

    The best

    BeOne Medicines Ltd.

    VALUE SCORE:

    9

    Symbol
    ONC
    Market Cap
    37.578B
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -1.375
    P/S
    0.519
    P/B
    -0.087
    Debt/Equity
    -0.195
    EV/FCF
    -37.812
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    1.785
    Earnings yield
    -0.727
    Debt/assets
    9.542
    FUNDAMENTALS
    Net debt/ebidta
    -17.862
    Interest coverage
    -1.989
    Research And Developement To Revenue
    0.009
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.002
    Capex to revenue
    0.000
    Capex to depreciation
    0.281
    Return on tangible assets
    -3.101
    Debt to market cap
    2.479
    Piotroski Score
    FUNDAMENTALS
    PEG
    -0.002
    P/CF
    -12.266
    P/FCF
    -11.049
    RoA %
    -310.120
    RoIC %
    44.030
    Gross Profit Margin %
    13.923
    Quick Ratio
    0.158
    Current Ratio
    0.209
    Net Profit Margin %
    -41.850
    Net-Net
    -17.878
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.137
    Revenue per share
    2.892
    Net income per share
    -1.210
    Operating cash flow per share
    -0.136
    Free cash flow per share
    -0.137
    Cash per share
    0.065
    Book value per share
    -17.685
    Tangible book value per share
    -17.685
    Shareholders equity per share
    -19.110
    Interest debt per share
    3.834
    TECHNICAL
    52 weeks high
    6.430
    52 weeks low
    0.205
    Current trading session High
    0.248
    Current trading session Low
    0.231
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    -1.3233986%
    P/E
    -6.053
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -6.645
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -9.884
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    33.788
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -29.926
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -16.861
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -293.344
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -5.697
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.912
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -36.218
    DESCRIPTION

    Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

    NEWS
    https://images.financialmodelingprep.com/news/rosen-a-top-ranked-law-firm-encourages-pomdoctor-ltd-20260225.jpg
    ROSEN, A TOP RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM

    globenewswire.com

    2026-02-25 18:14:00

    NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the “Class Period”), of the important April 7, 2026 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/rosen-skilled-investor-counsel-encourages-pomdoctor-ltd-investors-to-20260225.jpg
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM

    newsfilecorp.com

    2026-02-25 15:50:00

    New York, New York--(Newsfile Corp. - February 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/pom-investors-with-large-losses-should-contact-robbins-llp-20260224.jpg
    POM Investors with Large Losses Should Contact Robbins LLP for Information About the POMDoctor Ltd. Securities Class Action Lawsuit

    prnewswire.com

    2026-02-24 20:07:00

    San Diego, Feb. 24, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025.

    https://images.financialmodelingprep.com/news/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-pomdoctor-20260224.jpg
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM

    globenewswire.com

    2026-02-24 17:10:00

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PomDoctor Ltd. (“PomDoctor” or the “Company”) (NASDAQ: POM).   Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

    https://images.financialmodelingprep.com/news/shareholders-who-lost-money-in-american-depositary-receipts-of-20260224.jpg
    Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately

    prnewswire.com

    2026-02-24 07:38:00

    Lead Plaintiff Deadline is April 6, 2026 NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against PomDoctor, Ltd. (NASDAQ: POM) ("PomDoctor" or the "Company") inclusive on behalf of all persons and entities that purchased or otherwise acquired PomDoctor American Depositary Receipts ("ADR's") between October 9, 2025 and December 11, 2025, both dates inclusive (the "Class Period").

    https://images.financialmodelingprep.com/news/pom-investor-deadline-approaching-faruqi-faruqi-llp-reminds-pomdoctor-20260223.jpg
    POM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026

    newsfilecorp.com

    2026-02-23 20:39:00

    Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Pomdoctor To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Pomdoctor between October 9, 2025 and December 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - February 23, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

    https://images.financialmodelingprep.com/news/pom-investors-have-opportunity-to-lead-pomdoctor-ltd-securities-20260223.jpg
    POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit

    prnewswire.com

    2026-02-23 17:25:00

    NEW YORK, Feb. 23, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/rosen-a-global-investor-rights-law-firm-encourages-pomdoctor-20260222.jpg
    ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM

    newsfilecorp.com

    2026-02-22 18:21:00

    New York, New York--(Newsfile Corp. - February 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/rosen-a-highly-ranked-law-firm-encourages-pomdoctor-ltd-investors-20260221.jpg
    ROSEN, A HIGHLY RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM

    newsfilecorp.com

    2026-02-21 18:21:00

    New York, New York--(Newsfile Corp. - February 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/bragar-eagel-squire-pc-reminds-investors-that-class-action-20260221.jpeg
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PomDoctor and Vistagen and Encourages Investors to Contact the Firm

    globenewswire.com

    2026-02-21 12:35:00

    NEW YORK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel and Squire, P. C. , a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of PomDoctor, Ltd. (NASDAQ: POM) and Vistagen Therapeutics, Inc.

    https://images.financialmodelingprep.com/news/rosen-a-highly-ranked-law-firm-encourages-pomdoctor-ltd-20260221.jpg
    ROSEN, A HIGHLY RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM

    globenewswire.com

    2026-02-21 09:50:00

    NEW YORK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the “Class Period”), of the important April 7, 2026 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/rosen-a-leading-law-firm-encourages-pomdoctor-ltd-investors-20260220.jpg
    ROSEN, A LEADING LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM

    newsfilecorp.com

    2026-02-20 18:16:00

    New York, New York--(Newsfile Corp. - February 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/pom-shareholder-action-reminder-faruqi-faruqi-llp-reminds-pomdoctor-20260220.jpg
    POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026

    prnewswire.com

    2026-02-20 09:41:00

    Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Pomdoctor To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Pomdoctor between October 9, 2025 and December 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 20, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

    https://images.financialmodelingprep.com/news/scottscott-attorneys-at-law-llp-files-securities-class-action-20260220.jpg
    Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM)

    businesswire.com

    2026-02-20 09:00:00

    NEW YORK--(BUSINESS WIRE)---- $POM #POM--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants PomDoctor Ltd., Zhenyang Shi, Li Xu, Cogency Global, Joseph Stone Capital, LLC, and Marcum Asia CPAs, LLP (collectively, the “Defendants”). The action, which was filed in the U.S. District Court for the Southern District of New York and captioned Louie v. PomDoctor Ltd. et al., Ca.

    https://images.financialmodelingprep.com/news/rosen-a-global-and-leading-law-firm-encourages-pomdoctor-20260219.jpg
    ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM

    globenewswire.com

    2026-02-19 22:26:00

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the “Class Period”), of the important April 7, 2026 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-pomdoctor-20260219.jpg
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines - POM

    prnewswire.com

    2026-02-19 20:04:00

    NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PomDoctor Ltd. ("PomDoctor" or the "Company") (NASDAQ: POM).